Associate, Life Sciences Investments at R1 Capital
Check size: R1 Capital does not publish a standard person-specific check-size range on its current website.
Meghan Hoffman invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof of concept through growth using a national network and Rev1 partnership.
Show the technical moat, capital-efficient milestones, market scale, customer traction, team gaps and how R1 and Rev1 resources can accelerate the next critical stage.
Technical advantage, capital efficiency, scalable markets and founders who can turn early traction into industry-defining companies.
No formal pass list is public. Businesses without technical differentiation, capital discipline or a large scalable market appear less aligned.